Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Released By Bachem Case Studies Leading the Octreotide Scale-Up A Generics Case Study Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis Released By Bachem News Releases [WEBINAR] Tag-assisted one-pot liquid-phase oligonucleotide synthesis The webinar will take place on November 15, 2023 at 11:00 AM ET / 8:00 AM PT / 17:00 CET Released By Bachem News Releases Visit Bachem at CPhI Worldwide 2023 Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing
/assets/production/practices/52dfaec20b2342223cd4011f8bcdf3c234876a65/images/2830634.png)
Real-world effectiveness of GLP-1 receptor agonists in clinical practice
(A) Non-PT UMAP colored by eleven-grained cell-state clusters
The market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, is still new and continuously evolving
Patients in South Florida are being urged to sit down with their clinician to map out treatment goals, how side effects will be monitored and what realistic expectations look like for how long they may stay on a drug and what followup will involve
US$ 24.56
US$ 21.38
US$ 25.20
US$ 20.84
